Mostrar el registro sencillo del ítem
dc.contributor.author | Musigk, Nicolas | |
dc.contributor.author | Suwalski, Phillip | |
dc.contributor.author | Golpour, Ainoosh | |
dc.contributor.author | Fairweather, DeLisa | |
dc.contributor.author | Klingel, Karin | |
dc.contributor.author | Martin, Pilar | |
dc.contributor.author | Frustaci, Andrea | |
dc.contributor.author | Cooper, Leslie T | |
dc.contributor.author | Lüscher, Thomas F | |
dc.contributor.author | Landmesser, Ulf | |
dc.contributor.author | Heidecker, Bettina | |
dc.date.accessioned | 2024-07-09T12:09:48Z | |
dc.date.available | 2024-07-09T12:09:48Z | |
dc.date.issued | 2024 | |
dc.identifier.citation | Front Cardiovasc Med. 2024 Feb 23:11:1251780. | es_ES |
dc.identifier.issn | 2297-055X | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/20352 | |
dc.description.abstract | Infiltration of the myocardium with various cell types, cytokines and chemokines plays a crucial role in the pathogenesis of cardiomyopathies including inflammatory cardiomyopathies and myocarditis. A more comprehensive understanding of the precise immune mechanisms involved in acute and chronic myocarditis is essential to develop novel therapeutic approaches. This review offers a comprehensive overview of the current knowledge of the immune landscape in cardiomyopathies based on etiology. It identifies gaps in our knowledge about cardiac inflammation and emphasizes the need for new translational approaches to improve our understanding thus enabling development of novel early detection methods and more effective treatments. | es_ES |
dc.description.sponsorship | This work was supported by National Institutes of Health (NIH) R01 HL164520, R21 AI145356, R21 AI152318, R21 AI154927 to DF; American Heart Association 20TPA35490415 to DF; NIH grants TL1 TR002380 to DF; the For Elyse Foundation to DF; and Mayo Clinic Center for Regenerative Medicine to DF. PM is supported by MCIN-ISCIII-Fondo de Investigación Sanitaria (PI22/01759), (PMPTA22/00090-BIOCARDIOTOX) and Comunidad de Madrid (P2022/BMD-7209-INTEGRAMUNE-CM). | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Frontiers Media | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.title | The inflammatory spectrum of cardiomyopathies. | es_ES |
dc.type | review article | es_ES |
dc.rights.license | Atribución 4.0 Internacional | * |
dc.identifier.pubmedID | 38464847 | es_ES |
dc.format.volume | 11 | es_ES |
dc.format.page | 1251780 | es_ES |
dc.identifier.doi | 10.3389/fcvm.2024.1251780 | es_ES |
dc.contributor.funder | National Institutes of Health (Estados Unidos) | es_ES |
dc.contributor.funder | American Heart Association | es_ES |
dc.contributor.funder | Ministerio de Ciencia e Innovación (España) | es_ES |
dc.contributor.funder | Instituto de Salud Carlos III | es_ES |
dc.description.peerreviewed | Sí | es_ES |
dc.relation.publisherversion | 10.3389/fcvm.2024.1251780 | es_ES |
dc.identifier.journal | Frontiers in cardiovascular medicine | es_ES |
dc.repisalud.orgCNIC | CNIC::Grupos de investigación::Moléculas Reguladoras de los Procesos Inflamatorios | es_ES |
dc.repisalud.institucion | CNIC | es_ES |
dc.rights.accessRights | open access | es_ES |
dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/PI22/01759 | es_ES |
dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/PMPTA22/00090-BIOCARDIOTOX | es_ES |
dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/P2022/BMD-7209-INTEGRAMUNE-CM | es_ES |